Pamprin Cramp Menstrual Pain Relief

Product NDC
41167-3002
11-digit product format
411673002
Labeler code
41167
Product ID
41167-3002_090ab462-57db-4087-8fa8-712ecfa5af50
Type
HUMAN OTC DRUG
Nonproprietary name
Acetaminophen and Magnesium Salicylate and Pamabrom
Dosage form
TABLET
Route
ORAL
Labeler
Chattem, Inc.
Application
part343
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
1983-01-01
Marketing end
0000-00-00
Substance
ACETAMINOPHEN; MAGNESIUM SALICYLATE; PAMABROM
Active strength
250 mg/1; mg/1; mg/1
NDC exclude flag
No
Listing certified through
2019-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct41167-3002DDiscontinued by firm2026-10-05
excluded packagepackage41167-300241167-3002-1DDiscontinued by firm2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage41167-3002-1d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage41167-3002-1f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage41167-3002-12ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage41167-3002-1a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage41167-3002-1cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage41167-3002-1cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage41167-3002-1302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage41167-3002-1ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage41167-3002-10efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage41167-3002-1ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage41167-3002-1367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage41167-3002-1557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ACETAMINOPHENACTIVE INGREDIENT362O9ITL9DPAMPRIN CRAMP MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND MAGNESIUM SALICYLATE AND PAMABROM) TABLET [CHATTEM, INC.]5
MAGNESIUM SALICYLATEACTIVE INGREDIENT41728CY7UXPAMPRIN CRAMP MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND MAGNESIUM SALICYLATE AND PAMABROM) TABLET [CHATTEM, INC.]5
PAMABROMACTIVE INGREDIENTUA8U0KJM72PAMPRIN CRAMP MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND MAGNESIUM SALICYLATE AND PAMABROM) TABLET [CHATTEM, INC.]5
ACETAMINOPHENACTIVE MOIETY362O9ITL9DPAMPRIN CRAMP MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND MAGNESIUM SALICYLATE AND PAMABROM) TABLET [CHATTEM, INC.]5
BROMOTHEOPHYLLINEACTIVE MOIETYFZG87K1MQ6PAMPRIN CRAMP MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND MAGNESIUM SALICYLATE AND PAMABROM) TABLET [CHATTEM, INC.]5
SALICYLIC ACIDACTIVE MOIETYO414PZ4LPZPAMPRIN CRAMP MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND MAGNESIUM SALICYLATE AND PAMABROM) TABLET [CHATTEM, INC.]5
CARNAUBA WAXINACTIVE INGREDIENTR12CBM0EIZPAMPRIN CRAMP MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND MAGNESIUM SALICYLATE AND PAMABROM) TABLET [CHATTEM, INC.]5
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UPAMPRIN CRAMP MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND MAGNESIUM SALICYLATE AND PAMABROM) TABLET [CHATTEM, INC.]5
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48PAMPRIN CRAMP MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND MAGNESIUM SALICYLATE AND PAMABROM) TABLET [CHATTEM, INC.]5
CROSPOVIDONEINACTIVE INGREDIENT68401960MKPAMPRIN CRAMP MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND MAGNESIUM SALICYLATE AND PAMABROM) TABLET [CHATTEM, INC.]5
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBDPAMPRIN CRAMP MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND MAGNESIUM SALICYLATE AND PAMABROM) TABLET [CHATTEM, INC.]5
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOPAMPRIN CRAMP MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND MAGNESIUM SALICYLATE AND PAMABROM) TABLET [CHATTEM, INC.]5
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30PAMPRIN CRAMP MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND MAGNESIUM SALICYLATE AND PAMABROM) TABLET [CHATTEM, INC.]5
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1APAMPRIN CRAMP MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND MAGNESIUM SALICYLATE AND PAMABROM) TABLET [CHATTEM, INC.]5
POLYSORBATE 80INACTIVE INGREDIENT6OZP39ZG8HPAMPRIN CRAMP MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND MAGNESIUM SALICYLATE AND PAMABROM) TABLET [CHATTEM, INC.]5
POVIDONEINACTIVE INGREDIENTFZ989GH94EPAMPRIN CRAMP MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND MAGNESIUM SALICYLATE AND PAMABROM) TABLET [CHATTEM, INC.]5
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3PAMPRIN CRAMP MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND MAGNESIUM SALICYLATE AND PAMABROM) TABLET [CHATTEM, INC.]5
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4PAMPRIN CRAMP MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND MAGNESIUM SALICYLATE AND PAMABROM) TABLET [CHATTEM, INC.]5
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJPAMPRIN CRAMP MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND MAGNESIUM SALICYLATE AND PAMABROM) TABLET [CHATTEM, INC.]5
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APPAMPRIN CRAMP MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND MAGNESIUM SALICYLATE AND PAMABROM) TABLET [CHATTEM, INC.]5
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPPAMPRIN CRAMP MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND MAGNESIUM SALICYLATE AND PAMABROM) TABLET [CHATTEM, INC.]5